Dr. Falk Pharma GmbH, a Germany-headquartered research-based pharmaceutical company specialising in digestive and metabo...
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical...
GSK plc has entered into agreements with China-based Hengrui Pharma to develop up to 12 innovative medicines, adding sig...
A cross-disciplinary research team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine and Facul...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that f...
China Medical System Holdings Limited (CMS) has collaberated with the Singapore Exchange (SGX), expanding Chinese medica...
China-based Fangzhou Inc., a leader in internet healthcare solutions, has signed a Memorandum of Understanding (MoU) wit...
China's Sino Biopharm has announced the completion of a binding Sale and Purchase Agreement to acquire LaNova Medicines....
Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...
In the newly released "Paediatric drug optimisation for respiratory syncytial virus (PADO-RSV) meeting report" by Global...
Novo Nordisk has signed a Memorandum of Understanding (MoU) with TEDA Administrative Commission, agreeing to invest appr...
The Hong Kong Polytechnic University (PolyU) has signed a Memorandum of Understanding (MoU) with the Peking Union Medica...
Cornerstone Robotics has announced the launch of its first formal clinical investigation of its Hong Kong-developed surg...
China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...
Dr Jeremy Teoh Yuen-chun, Assistant Dean (External Affairs) and Associate Professor from the Division of Urology in the ...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and The Hong Kong Sports Institute ...
Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across disea...
Switzerland-headquartered Ypsomed has opened its first dedicated production site in China. The new facility, located in ...
